6505--Clobetasol Cream and Ointment (VA-25-00041429)
ID: 36E79725R0040Type: Solicitation
AwardedSep 16, 2025
$6.3M$6,333,470
AwardeeENCUBE ETHICALS, INC DURHAM 27713 NCL
Award #:36E79725D0056
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/614ecea876d24b07a7a8c76b580e51c5/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the supply of Clobetasol Cream and Ointment as part of its pharmaceutical procurement efforts. This opportunity is aimed at ensuring a consistent supply of these essential pharmaceutical products, which are critical for treating various dermatological conditions. The contract will be structured with a base year and four optional renewal years, emphasizing compliance with FDA standards and the Drug Supply Chain Security Act, while also requiring detailed reporting and adherence to Good Manufacturing Practices. Interested bidders should note that the deadline for submitting offers has been extended to June 17, 2025, at 2:30 PM Central Time, and must acknowledge receipt of the amendment to remain eligible. For further inquiries, potential contractors can contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov.

    Point(s) of Contact
    Nicholas I McGregorContract Specialist
    Nicholas.McGregor@va.gov
    Files
    Title
    Posted
    36E79725R0040_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue Request for Proposal (RFP) 36E79725R0040 for an unrestricted procurement of Clobetasol Propionate 0.05% Cream and Ointment. This procurement is intended for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will be awarded for two groups: Group I (Cream) and Group II (Ointment), with requirements including specified package sizes and estimated annual usage for each item. The contract duration is one year, with an option for four additional years. Offerors must provide unique NDC numbers and ensure packaging compliance. The solicitation is set for electronic release around May 22, 2025, with a closing date of June 5, 2025. Interested parties should consistently check SAM.gov for updates, as no paper copies will be provided. The estimated usage includes 64,807 tubes of 15-gram Clobetasol Cream and 73,820 tubes of 15-gram Clobetasol Ointment, among others. The point of contact for inquiries is Contract Specialist Ray Roldan, reachable via email.
    36E79725R0040.docx
    This document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs for pharmaceutical supplies, specifically focusing on Clobetasol Cream and Ointment, as part of the Veterans Affairs and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation provides detailed instructions for potential contractors regarding submission requirements, including the need for a Letter of Commitment from manufacturers if the offeror acts as a distributor. The contract allows for a base year with four optional renewal years, encouraging bulk pricing and ensuring consistent product delivery. Additionally, it emphasizes regulatory compliance with FDA standards, the Drug Supply Chain Security Act (DSCSA), and the necessity of providing unique National Drug Codes (NDC) for each product. Key points include pricing structures that must include a 0.5% Cost Recovery Fee, detailed reporting for sales, and stipulations around ensuring products meet Good Manufacturing Practices (cGMP). The RFP concludes by detailing the administrative requirements and compliance expectations to ensure orderly processing of contracts and obligations under federal procurement regulations. The document is structured with sections addressing the solicitation, proposal requirements, contract Clauses, and a thorough scope of contract that addresses potential product backorders and pricing transparency.
    36E79725R0040 0001.docx
    This document is an amendment to solicitation number 36E79725R0040, issued by the Department of Veterans Affairs' OPAL/National Acquisition Center, extending the deadline for offers. The original due date of June 10, 2025, has been postponed to June 17, 2025, at 2:30 PM Central Time. The amendment seeks to ensure that all interested bidders are granted additional time to prepare and submit their proposals. Aside from this change, all other terms and conditions associated with the solicitation remain unchanged. The amendment requires offerors to acknowledge receipt by specified methods to retain their eligibility for consideration. This extension reflects the department's commitment to provide ample opportunities for participation in federally funded projects, aligning with the protocols of government Requests for Proposals (RFPs).
    Similar Opportunities
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    Tretinoin Cream
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Tretinoin Cream. The cream is used for various dermatological conditions and comes in different strengths (0.025%, 0.05%, and 0.1%) and tube sizes (20G and 45G). The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. It will establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The annual usage estimates will be provided in the solicitation. Interested parties should contact Ryan Ferry for more information. The projected solicitation date is February 2023.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Tucson CMOP COAL TAR 2% SHAMPOO 240ML AND MOISTURIZING LOTION
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought Notice for domestically manufactured pharmaceuticals, specifically COAL TAR 2% SHAMPOO and MOISTURIZING LOTION, for its Consolidated Mail Outpatient Pharmacy (CMOP) program in Tucson, Arizona. This market research effort aims to identify qualified small and large business manufacturers or distributors capable of supplying these products, which are essential for treating various dermatological conditions. Interested parties must respond by December 15, 2025, at 16:00 CDT, providing necessary company information and ensuring registration in SAM, with inquiries directed to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935. This notice does not guarantee a contract award but facilitates early information exchange.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.